The Inflammatory Response to Ventricular Assist Devices
The therapeutic use of ventricular assist devices (VADs) for end-stage heart failure (HF) patients who are ineligible for transplant has increased steadily in the last decade. In parallel, improvements in VAD design have reduced device size, cost, and device-related complications. These complication...
Main Authors: | Gemma Radley, Ina Laura Pieper, Sabrina Ali, Farah Bhatti, Catherine A. Thornton |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-11-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2018.02651/full |
Similar Items
-
Right ventricular failure following left ventricular assist device implantation is associated with a preoperative pro-inflammatory response
by: Paul C. Tang, et al.
Published: (2019-04-01) -
Implantation of Short-Term and Long-Term Right Ventricular Assist Devices
by: Christiano Castello Branco Caldeira, et al. -
Ablation of ventricular tachycardia in a patient with a left ventricular assist device
by: Evrim Şimşek, et al.
Published: (2020-01-01) -
Clinical outcome in patients with end-stage heart failure who underwent continuous-flow left ventricular assist devices in a single center
by: Yoonjee Park, et al.
Published: (2022-03-01) -
The effect of transfusion of blood products on ventricular assist device support outcomes
by: Supriya Shore, et al.
Published: (2020-12-01)